Elbert L B, Nelga I V, Grishina G K, Dunaevski O A, Kharin N V, Drozdov S G, Balayan M S
Institute of Poliomyelitis and Viral Encephalitides, Moscow State Medical Institute, USSR.
Vaccine. 1991 Aug;9(8):540-1. doi: 10.1016/0264-410x(91)90238-2.
An inactivated hepatitis A virus (HAV) vaccine was tested on a group of human adult volunteers. The vaccine was administered subcutaneously, and a control group received a placebo (aluminium hydroxide). The vaccine was found to be relatively well tolerated and non-reactogenic, and levels of anti-HAV were comparable to those in other studies.
Zotero 插件